SFO
AMED

Standard Family Office’s Amedisys AMED Stock Holding History

Standard Family Office’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-48
Closed -$12K – 91
2021
Q2 		$12K Hold
48
– – ﹤0.01% 253
2021
Q1 		$13K Buy
48
+16
+50% +$4.51K ﹤0.01% 310
2020
Q4 		$9K Buy
+32
New +$8.21K ﹤0.01% 314

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Standard Family Office's AMED Position: Q3 2021 in Review

Standard Family Office sold out of Amedisys (AMED) in Q3 2021, closing a stake of 48 shares — an estimated $12K sold.

Standard Family Office first reported a position in AMED in Q4 2020 and held it in 3 quarters. The position peaked at $13K in Q1 2021. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Standard Family Office reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Standard Family Office sold 48 Amedisys shares in Q3 2021, an estimated $12K.
  • Standard Family Office first reported a position in Amedisys in Q4 2020 and held it in 3 quarters.
  • Standard Family Office's Amedisys position peaked at $13K in Q1 2021.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Standard Family Office's 13F filing for Q3 2021, filed 15 Nov 2021.